title: Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults?
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Musher
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000382:microbiology* / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000276:immunology*; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000276:immunology*
chemical_list: C538862:13-valent pneumococcal vaccine; C414006:23-valent pneumococcal capsular polysaccharide vaccine; D022242:Pneumococcal Vaccines